Keyphrases
COVID-19
63%
Antiretroviral Therapy
41%
Confidence Interval
41%
AIDS/HIV
36%
West Nile Virus
35%
Virus
34%
Clostridium Difficile Infection
32%
People Living with HIV (PLHIV)
31%
United States
28%
Monoclonal Antibody
24%
Risk Factors
23%
Lymphatic Filariasis
22%
HIV Patients
22%
West Nile Virus Infection
22%
Plasmodium Falciparum
21%
Antibiotics
18%
T Cells
18%
Interferon-α (IFN-α)
18%
Surgical Site Infection
18%
Central Nervous System
18%
Nematodes
17%
Zika Virus
17%
Microfilaria
17%
Enterotoxigenic Escherichia Coli
15%
Intensive Care Unit
15%
HIV Care
15%
Mass Drug Administration
15%
Epidemiology
15%
Dengue Virus
15%
Infectious Diseases
15%
Odds Ratio
14%
Epitope
14%
Infection Rate
14%
Flavivirus
14%
Viral Infection
14%
Human Immunodeficiency Virus Type 1 (HIV-1)
14%
Brugia Malayi
13%
Immune Response
13%
Escherichia Coli
13%
Mycobacterium Tuberculosis (M. tb)
13%
Chikungunya Virus (CHIKV)
12%
Bloodstream Infection
12%
CD8+ T Cells
12%
Neutralizing Antibodies
12%
Albendazole
12%
HIV Infection
12%
Ivermectin
11%
Influenza Virus
11%
Emergency Department
11%
Diethylcarbamazine
11%
Vaccination
11%
Clostridioides Difficile
10%
Dendritic Cells
10%
Zambia
10%
Innate Immune Response
10%
Hospitalization
10%
Infection Prevention
10%
Hemoglobin
10%
High Risk
10%
Macrophages
10%
Sub-Saharan Africa
10%
Antimicrobial Resistance
10%
Wuchereria Bancrofti
10%
Randomized Controlled Trial
10%
COVID-19 Pandemic
10%
Hospitalized Patients
10%
Parasitic Nematode
10%
Lung
10%
Nigeria
10%
Onchocerca Volvulus
10%
Malaria Parasite
9%
Filarial
9%
Antibody Response
9%
Methicillin-resistant Staphylococcus Aureus
9%
Tertiary Care Hospital
9%
Recombinant
9%
Clinical Outcomes
9%
Filariasis
9%
Adjusted Odds Ratio
9%
Plasmepsin
9%
Onchocerciasis
9%
Inflammation
9%
Missouri
9%
Bancroftian Filariasis
9%
Health Personnel
9%
Healthcare
9%
Viral
8%
Difficile
8%
Microbiota
8%
Tuberculosis
8%
Meta-analysis
8%
Type I Interferon
8%
Alphavirus
8%
Sepsis
8%
CD4 Count
8%
Antimicrobial
8%
Healthcare Workers
8%
Zika Virus Infection
8%
Urinary Tract Infection
8%
Murine Norovirus
8%
Immunology and Microbiology
Immunology
59%
Viral Disease
57%
West Nile Virus
41%
Human Immunodeficiency Virus
40%
Infectious Agent
37%
Severe Acute Respiratory Syndrome Coronavirus 2
35%
interferon
30%
T Cell
26%
Nematode
22%
Monoclonal Antibody
21%
Immunity
20%
Epitope
20%
Immune Response
18%
Cytotoxic T-Cell
17%
Plasmodium falciparum
17%
Escherichia coli
17%
Human Immunodeficiency Virus 1
16%
Central Nervous System
16%
Neutralization
15%
Dengue Virus
15%
Prevalence
15%
Macrophage
15%
Plasmodium
15%
Parasitology
14%
Flavivirus
14%
Neutralizing Antibody
14%
Filariasis
13%
Zika Virus
13%
Viral Replication
13%
Innate Immune System
13%
Enterotoxigenic Escherichia Coli
12%
Lymphatic Filariasis
12%
Brugia malayi
11%
Peptoclostridium difficile
11%
Dendritic Cell
11%
Mycobacterium Tuberculosis
11%
Spike
10%
Antibody Response
10%
B Cell
10%
Chikungunya Virus
10%
COVID-19
10%
Glycoprotein
10%
Alphavirus
9%
Microbiome
9%
Cytokine
8%
Blood Plasma
8%
Serotype
8%
Microflora
8%
Viral Load
8%
Plasmepsin
8%
RNA Virus
8%
Influenza
8%
Norovirus
8%
Wild Type
8%
Wuchereria bancrofti
8%
Human Immunodeficiency Virus Infection
8%
Gene Expression
8%
Host Cell
8%
Microorganism
7%
Staphylococcus Aureus
7%
Murine Norovirus
7%
Ebola Virus
7%
Parasitic Nematodes
7%
Influenza Virus
7%
Infectious Disease
7%
Intestine Flora
7%
Cladistics
7%
Microfilaria (Nematode Larva)
7%
Albendazole
7%
Methicillin-Resistant Staphylococcus Aureus
7%
Microfilaria
7%
Lymph Node
7%
CD4 Lymphocyte Count
7%
Wolbachia
7%
Diethylcarbamazine
7%
Antimicrobial Resistance
7%
Receptor Binding
6%
T-Helper Cell
6%
Helminth
6%
Amino Terminal Sequence
6%
Human Monoclonal Antibody
6%
Onchocerca volvulus
6%
Adaptive Immune System
6%
Blood Brain Barrier
6%
Neutrophil Granulocyte
6%
Lineages
6%
Mouse Model
6%
Onchocerciasis
6%
CD4
6%
Virion
6%
Erythrocyte
6%
Urinary Tract
6%
Secretion (Process)
6%
Omicron Coronavirus Variant
6%
Neutrophil
6%
Maturation
5%
Cytotoxic T Cell
5%
Influenzavirus A
5%
Cytomegalovirus
5%
Dynamics
5%
Medicine and Dentistry
Infection
100%
Human Immunodeficiency Virus
95%
Disease
39%
COVID-19
34%
Severe Acute Respiratory Syndrome Coronavirus 2
27%
Antiretroviral Therapy
27%
Prevalence
20%
Clostridium Difficile Infection
18%
Cohort Effect
17%
Lymphatic Filariasis
17%
Surgical Infection
17%
Bloodstream Infection
17%
Pathogen
16%
Odds Ratio
15%
Antibiotics
14%
Intensive Care Unit
14%
Diagnosis
13%
Antiinfective Agent
13%
Health Care Cost
12%
Drug Administration
11%
Emergency Department
11%
Public Health
10%
Systematic Review
10%
Randomized Controlled Trial
10%
Virus Infection
10%
Infection Prevention
9%
Clinician
9%
Human Immunodeficiency Virus Infection
9%
Sepsis
8%
Health Care
8%
Ivermectin
8%
Antivirus Agent
8%
Adolescence
8%
Albendazole
8%
Outpatient
8%
Onchocerciasis
8%
Tertiary Care
8%
Interferon
7%
Drug Therapy
7%
Cohort Analysis
7%
Adverse Event
7%
Clinical Trial
7%
Nematoda
7%
Infection Rate
7%
Antibiotic Resistance
7%
Injury
7%
Transplantation
7%
Comorbidity
7%
In Vitro
6%
Meta-Analysis
6%
Urinary Tract Infection
6%
Immunity
6%
Lung
6%
Hazard Ratio
6%
Diethylcarbamazine
6%
Zika Virus
6%
Central Nervous System
6%
T Cell
6%
Peptoclostridium difficile
6%
Onchocerca volvulus
6%
Infection Control
6%
Low and Middle Income Countries
6%
Pediatrics
5%
Logistic Regression Analysis
5%
Cytomegalovirus Infection
5%
Antibiotic Therapy
5%
Catheter Infection
5%
Coronavirinae
5%
Emergency Care
5%
West Nile Virus
5%
Cardiovascular Disease
5%
Antimicrobial Therapy
5%
Cytomegalovirus
5%
Immune Response
5%
Healthcare Associated Infection
5%
Retrospective Cohort Study
5%
Placebo
5%
Consultation
5%